EpiVax's competitors

EpiVax's competitors include InVitae, International Stem Cell Corporation, Cord Blood America and Synthace
Add company...
EpiVax
EpiVax has developed comprehensive analytical capabilities in the field of computational immunology.
InVitae
InVitae provides genetic diagnostics for hereditary disorders.
International Stem Cell Corporation
International Stem Cell Corporation is a California-based biotechnology company focused on therapeutic and research products.
Cord Blood America
Cord Blood America, Inc. provides cord blood and cord tissue stem cell services.
Synthace
Synthace produces bio-based chemical products through the application of synthetic biology.
Founding Date
Founding Date
1998
Founding Date
2010
Founding Date
2001
Founding Date
1999
Founding Date
2011
Type
Type
Private
Type
Public
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
Providence, US HQ
Locations
San Francisco, US HQ
Locations
Carlsbad, US HQ
Locations
Las Vegas, US HQ
Locations
London, GB HQ
Employees
Employees
39
Employees
364 19% increase
Employees
41
Employees
15
Employees
33 6% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
312.5 m
Valuation ($)
6.7 m
Valuation ($)
3.7 m
Valuation ($)
N/A
Facebook followers
Facebook followers
71
Facebook followers
23.6 k
Facebook followers
3.9 k
Facebook followers
N/A
Facebook followers
62
Twitter followers
Twitter followers
235
Twitter followers
5.1 k
Twitter followers
10.1 k
Twitter followers
N/A
Twitter followers
471

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$25m (FY, 2016)
Revenue (est.)
$7.2b (FY, 2016)
Revenue (est.)
$3.3m (FY, 2016)
Revenue (est.)
£581 (FY, 2013)
Cost of goods
Cost of goods
N/A
Cost of goods
$27.9m (FY, 2016)
Cost of goods
$1.9b (FY, 2016)
Cost of goods
$904.9k (FY, 2016)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
($2.8m) (FY, 2016)
Gross profit
$5.2b (FY, 2016)
Gross profit
$2.4m (FY, 2016)
Gross profit
N/A
Net income
Net income
N/A
Net income
($100.3m) (FY, 2016)
Net income
($1.1b) (FY, 2016)
Net income
$102.2k (FY, 2016)
Net income
(£361.6k) (FY, 2013)

Funding

Latest funding round
Latest funding round
$ 55k (over 5 years ago)
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 9.9m (5 months ago)
Total funding raised
Total funding raised
$ 3.2m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 16.2m
For sources of this data, please see the company profileDownload Excel

View company profiles